Newsroom | 29461 results

LEMONT, Ill.--(BUSINESS WIRE)--Argonne partners in collaboration to turn water‑focused innovation into new technologies and businesses that strengthen the Great Lakes economy....

LOS ANGELES--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunology therapies for dermatologic conditions, today reported financial results for the year ended December 31, 2025, and provided corporate updates. “Our first months as a public company have been highly productive, with strong progress across our clinical, financial, and strategic priorities,” said Bradley Burnam, Chief Executive Officer of Turn T...

HELSINKI e BRUXELLES--(BUSINESS WIRE)--Il progetto TREASoURcE, finanziato dall'UE, presenterà i suoi risultati più salienti e i messaggi di politica alla Final Conference del 14 aprile 2026 a Bruxelles , che riunirà decisori politici, rappresentanti del settore, ricercatori, amministrazioni urbane e attori della società civile di tutta Europa. La conferenza di un giorno è dedicata a come le soluzioni dell'economia circolare possono passare da progetti pilota a implementazioni più ampie. Nell'ar...

HELSINKI & BRUSSEL--(BUSINESS WIRE)--Het door de EU gefinancierde TREASoURcE-project zal zijn belangrijkste resultaten en beleidsberichten voorstellen tijdens de Slotconferentie op 14 april 2026 in Brussel, waar beleidsmakers, vertegenwoordigers van de industrie, onderzoekers, steden en acteurs van de burgergemeenschap uit heel Europa samenkomen. De conferentie, die de hele dag in beslag neemt, richt de aandacht op de manier waarop oplossingen voor circulaire economie van pilootprojecten naar r...

HELSINKI ET BRUXELLES--(BUSINESS WIRE)--Le projet TREASoURcE, financé par l’Union européenne, présentera ses principaux résultats ainsi que ses recommandations stratégiques lors de sa conférence de clôture, qui se tiendra le 14 avril 2026 à Bruxelles. Cet événement réunira des décideurs politiques, des représentants du secteur privé, des chercheurs, des collectivités et des acteurs de la société civile venus de toute l’Europe. Organisée sur une journée complète, la conférence sera consacrée aux...

HELSINKI Y BRUSELAS--(BUSINESS WIRE)--El proyecto TREASoURcE, financiado por la UE, presentará sus principales resultados y mensajes políticos en la conferencia final que se celebrará el 14 de abril de 2026 en Bruselas, y que reunirá a responsables políticos, representantes del sector, investigadores, ciudades y actores de la sociedad civil de toda Europa. La conferencia, de un día de duración, se centrará en cómo las soluciones de economía circular pueden pasar de ser proyectos piloto a una im...

EDISON, N.J. & SALT LAKE CITY--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis®, an industry leading pure-play surgical biologics company, today announced the launch of DBX Fiber®, the latest addition to the DBX® family. For decades, DBX has been a trusted name in demineralized bone matrix, earning its reputation through proven performance in operating rooms around the w...

HELSINKI & BRÜSSEL--(BUSINESS WIRE)--Das von der EU finanzierte TREASoURcE-Projekt wird seine wichtigsten Ergebnisse und politischen Botschaften auf der Abschlusskonferenz am 14. April 2026 in Brüssel vorstellen und dabei politische Entscheidungsträger, Vertreter der Industrie, Forscher, Städte und Akteure der Zivilgesellschaft aus ganz Europa zusammenbringen. Die ganztägige Konferenz konzentriert sich darauf, wie Lösungen der Kreislaufwirtschaft den Sprung von Pilotprojekten zur breiteren Umse...

TORONTO--(BUSINESS WIRE)--In honour of International Women’s Month, OBIO® hosted a celebration of women leaders across the life sciences and health tech sectors. The event, supported by EY and FACIT, featured remarks by Chi Nguyen, Member of Parliament for Spadina — Harbourfront, and The Honourable Charmaine Williams, Associate Minister of Women’s Social and Economic Opportunity, a panel discussion on raising capital and scaling globally, and a pitch competition showcasing the nine women-led co...

SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode™ Whole Transcriptome FFPE kits that are now shipping to customers. This new solution is a breakthrough that enables true whole transcriptome single cell RNA sequencing from formalin-fixed, paraffin-embedded samples. Beginning today, cancer, neuroscience, and translational researchers can access...